We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Fluorescent nanomaterials smaller than 10 nm can disrupt drug-resistant bacteria through multiple mechanisms while enabling real-time imaging, offering a new direction in antimicrobial strategy development.